Endophthalmitis after cataract surgery: results from seven years of epidemiological surveillance / Endoftalmites após cirurgia de catarata: resultado de sete anos de vigilância epidemiológica

Abstract Purpose: This study aims to describe the incidence, clinical presentation, and evolution of endophthalmitis cases occurred at an ophthalmologic center in Brazil. Methods: This is a review of medical records of patients undergoing cataract surgery from 2008 to 2014. Clinical variables associated with the outcome of postoperative endophthalmitis were evaluated. Results: during the study period, 27,609 cataract surgeries were performed. It was identified 35 cases of endophthalmitis. The overall incidence of endophthalmitis was 0.13%, with an annual variation from 0.04% to 0.27%. The main signs and symptoms in patients with endophthalmitis were ocular pain and low visual acuity associated with conjunctival hyperemia and hypopyon. Gram-positive microorganisms were the most frequent etiological agents. All patients received an intra-vitreous injection of antibiotics as immediate treatment. The final visual acuity was equal to or worse than the ability to count the examiner's fingers in 57.1% of the patients. Evisceration or enucleation was required in 3 patients. Conclusion: The incidence of endophthalmitis and the majority of signs and symptoms found in this study were in agreement with literature in the field. Although the incidence rate is low, the loss of vision experienced by most patients with endophthalmitis after cataract surgery highlights the need for efforts to prevent infection and early diagnosis to avoid such complications.

Resumo Objetivo: Descrever a incidência, a apresentação clínica e a evolução dos casos de endoftalmites ocorridos em um centro oftalmológico no Brasil. Métodos: Trata-se de uma revisão de prontuários dos pacientes submetidos à cirurgia de catarata no período de 2008 a 2014. Foram avaliadas as variáveis clínicas associadas ao desfecho de endoftalmite pós-operatória. Resultados: durante o período do estudo, foram realizadas 27.609 cirurgias de catarata. Foram identificados 35 casos de endoftalmite. A incidência global de endoftalmite foi de 0,13%, com variação anual de 0,04% a 0,27%. Os principais sinais e sintomas em pacientes com endoftalmite foram dor ocular e baixa acuidade visual associado à hiperemia conjuntival e hipópio. Os microrganismos gram-positivos foram os agentes etiológicos mais frequentes. Todos os pacientes receberam uma injeção intravítreo de antibióticos como tratamento imediato. A acuidade visual final foi igual ou pior que a capacidade de contar os dedos do examinador em 57,1% dos pacientes. Evisceração ou enucleação foi necessário em 3 pacientes. Conclusão: A incidência de endoftalmite e a maioria dos sinais e sintomas encontrados neste estudo estão de acordo com os reportados na literatura. Embora a taxa de incidência seja baixa, a perda de visão experimentada pela maioria dos pacientes com endoftalmite após a cirurgia de catarata destaca a necessidade de esforços para medidas de prevenção de infecção e diagnóstico precoce para evitar tais complicações.

Effects of topical azithromycin, moxifloxacin, and povidone iodine on conjunctival bacterial flora in patients undergoing intravitreal injection / Os efeitos da azitromicina tópica, moxifloxacina e iodopovidona na flora bacteriana conjuntival em injeções intravítreas

ABSTRACT Purpose: To compare effects of 5% topical povidone iodine with prophylactic topical azithromycin and moxifloxacin on bacterial flora in patients undergoing intravitreal injection. Methods: A total of 132 patients were randomly assigned to receive treatment with azithromycin or moxifloxacin, or no treatment (control group). In total, 528 specimens were obtained at the time of admission, 4 days before intravitreal injection, 4 days after intravitreal injection, and 8 days after intravitreal injection. Samples were immediately sent to the microbiology laboratory for incubation. Results: The microorganism observed most frequently was coagulasenegative Staphylococcus (23.8%). When the results of samples obtained on Day 4 before injection were assessed, growth of coagulase-negative Staphylococcus was significantly lower in the moxifloxacin group, compared with controls (p=0.049). Acinetobacter baumannii continued to grow after administration of azithromycin (p=0.033). When the results of four days after intravitreal injection were evaluated, growth of coagulase-ne gative Staphylococcus was higher in controls, compared with patients who received azithromycin or moxifloxacin (p=0.004). Eradication rate was significantly higher in the moxifloxacin group than in the control group (p=0.001). Samples obtained on Day 8 after intravitreal injection showed similar levels of bacterial growth in all groups (p=0.217). Conclusion: Moxifloxacin was more effective than 5% povidone iodine in controlling the growth of conjunctival bacterial flora. Use of moxifloxacin in combination with 5% povidone iodine resulted in a synergistic effect.

RESUMO Objetivo: Comparar os efeitos de iodopovidona tópico a 5% com azitromicina e moxifloxacina profiláticas sobre a flora bacteriana em pacientes submetidos à injeção intravítrea. Métodos: Um total de 132 pacientes foram aleatoriamente designados para receber tratamento com azitromicina ou moxifloxacina ou nenhum tratamento (grupo controle). No total, 528 amostras foram obtidas no momento na admissão, 4 dias antes da injeção intravítrea, 4 dias após a injeção intravítrea e 8 dias após a injeção intravítrea. As amostras foram imediatamente enviadas para o laboratório de microbiologia para incubação. Resultados: O microorganismo mais frequentemente observado foi o Staphylococcus coagulase-negativo (23,8%). Quando os resultados das amostras obtidas no dia 4 antes da injeção foram avaliados, o crescimento do Staphylococcus coagulase-negativo foi significativamente menor no grupo mo xifloxacina, em comparação com os controles (p=0,049). Acinetobacter baumannii continuou a crescer após a administração de azitromicina (p=0,033). Quando os resultados de 4 dias após a injeção intravítrea foram avaliados, o crescimento do Staphylococcus coagulase-negativo foi maior no controle, em comparação com pacientes que receberam azitromicina ou moxifloxacina (p=0,004). A taxa de erradicação também foi significativamente maior no grupo moxifloxacina do que no grupo controle (p=0,001). As amostras obtidas no dia 8 após injeção intravítrea mostraram níveis semelhantes de crescimento bacteriano em todos os grupos (p=0,217). Conclusão: A moxifloxacina foi mais eficaz do que 5% de iodopovidona no controle do crescimento da flora bacteriana conjuntival. O uso de moxifloxacina em combinação com 5% de iodopovidona resultou em um efeito sinérgico.

Intracameral moxifloxacin after cataract surgery: a prospective study / Moxifloxacino intracameral após cirurgia da catarata: estudo prospectivo

ABSTRACT Objective: To study the safety parameters associated with intracameral moxifloxacin application five weeks after cataract surgery. Methods: The study was a prospective case series set in a private hospital in Recife, Pernambuco, Brazil. A consecutive sample of 1,016 cataract surgeries was evaluated. The inclusion criteria were patients with indications for cataract surgery, a minimum of 55 years of age, and no history of allergy to quinolones. Patients were prepared for surgery using a 5% povidone solution diluted as a topical antiseptic agent. The operative technique was phacoemulsification with intraocular lens implantation. A 0.3-mL syringe was partially filled with moxifloxacin and 150 µg/0.03 mL of moxifloxacin was administered through the surgical incision at the end of the surgery. Postoperatively, patients were prescribed: (1) 0.5% moxifloxacin eyedrops 5 times daily for 1 week, and (2) 1% prednisolone acetate eyedrops 5 times daily for 1 week, followed by 4 times daily for 1 week and, subsequently, 2 times daily for 3 weeks. The outcomes were incidence of acute endophthalmitis, mean changes from baseline to 5 postoperative weeks in corneal endothelial cell density, corrected distance visual acuity and intraocular pressure. Results: The mean age was 67 ± 5 years, and 56.2% of the patients were female. There were no cases of endophthalmitis. The mean preoperative corrected distance visual acuity was 58 letters ± 10 (SD), and the mean postoperative corrected distance visual acuity was 80 letters ± 4 (SD). The mean change in corneal endothelial cell density was 249 cells/mm (-10.3%). There was almost no difference in intraocular pressure. No study-related adverse events were observed. Conclusion: The results suggest moxifloxacin is a safe option for intracameral use after cataract surgery.

RESUMO Objetivo: Estudar alguns parâmetros de segurança da moxifloxacino intracameral nas cinco semanas após a cirurgia de catarata. Métodos: O estudo foi uma série de casos prospectivos. O cenário era um hospital privado em Recife, Pernambuco, Brasil. Foi considerada uma amostra consecutiva de 1.016 cirurgias de catarata. Os critérios de inclusão foram pacientes com indicação para cirurgia de catarata, com pelo menos 55 anos de idade e sem história de alergia a quinolonas. Os pacientes foram preparados para cirurgia usando uma solução de povidona a 5% diluída como agente anti-séptico tópico. A técnica operatória foi a facoemulsificação com implante de lente intraocular. Uma seringa de 0,3 mL foi parcialmente preenchida com moxifloxacino. Os pacientes receberam 150 µg/0,03 mL de moxifloxacino através da incisão cirúrgica no final da cirurgia. No pós-operatório, os pacientes foram prescritos: (1) moxifloxacino 0,5% 5 vezes ao dia durante 1 semana e (2) colírio de acetato de prednisolona a 1% 5 vezes ao dia durante 1 semana, seguido de 4 vezes ao dia durante 1 semana e, posteriormente, 2 vezes diariamente por 3 semanas. Os desfechos foram a incidência de endoftalmite aguda, variações entre os valores basais e os na 5ª semana pós-operatória referente à densidade celular endotelial corneana, acuidade visual corrigida para longe e pressão intraocular. Resultados: A média da idade foi de 67 ± 5 anos, e 56,2% dos pacientes eram do sexo feminino. Não houve casos de endoftalmite. A acuidade visual corrigida para longe préoperatório médio foi de 58 letras ± 10 (SD), e a acuidade visual corrigida para longe pósoperatório médio foi de 80 letras ± 4 (SD). A alteração média na densidade celular endotelial corneana foi de 249 células/mm (10,3%). Não houve diferença na pressão intraocular. Não foram observados eventos adversos relacionados ao estudo. Conclusão: Os resultados sugerem que o moxifloxacino é uma opção segura para o uso intracameral após a cirurgia de catarata.

Safety and efficacy of intracameral moxifloxacin injection for prophylaxis of endophthalmitis after phacoemulsification / Segurança e eficácia na injeção intracameral de moxifloxacino para profilaxia da endoftalmite após a facomeulsificação

ABSTRACT Purpose: To evaluate the safety and efficacy of 0.05 mL intracameral injection of moxifloxacin in patients who underwent phacoemulsification and intraocular lens (IOL) implant. Methods: Retrospective study comprising patients who underwent phacoemulsification and IOL implant between January 2009 and December 2013. Patients were divided into two groups. Group A followed standard endophthalmitis prevention protocol and group B followed the same protocol plus intracameral injection of 0.05 mL of moxifloxacin hydrochloride at 5.45 mg/mL, immediately after IOL implant. Results: Medical records from 7,195 eyes of 3,751 patients (median age: 67.8 ± 8.96, range: 48-83 years, 53.8% female) were evaluated. Group A included 3,515 eyes of 1,838 patients and group B included 3,680 eyes of 1,913 patients. The incidence of endophthalmitis in group A was 0.22% (8:3,515 eyes) and in group B was 0.03% (1:3,680 eyes, p=0.0198, Fischer's exact test). No toxicity or inflammation related to the use of moxifloxacin was observed. Conclusions: There was a 7.3-fold lower ratio of endophthalmitis in the group that received moxifloxacin intracameral injection. This study provides further evidence that moxifloxacin is an effective intracameral prophylactic antibiotic.

RESUMO Objetivo: Avaliar a segurança e a eficácia da injeção intracameral de 0,05 mL de moxifloxacina em pacientes que realizaram facoemulsificação e implante de lente intraocular. Métodos: Estudo retrospectivo envolvendo pacientes submetidos a facoemulsificação e implante de lente intraocular entre janeiro de 2009 a dezembro de 2013. Os pacientes foram divididos em dois grupos. O grupo A seguiu o protocolo padrão de prevenção de endoftalmite e o grupo B seguiu o mesmo protocolo associado à injeção intracameral de 0,05 mL de cloridrato de moxifloxacino a 5,45 mg/mL, imediatamente após o implante de lentes intra-oculares (LIO). Resultados: Foram avaliados registros clínicos de 7.195 olhos de 3.751 pacientes (mediana de idade de 67,8 ± 8,96, faixa de 48-83 anos, 53,8% de mulheres). O grupo A incluiu 3.515 olhos de 1.838 pacientes e o grupo B incluiu 3.680 olhos de 1.913 pacientes. A incidência de endoftalmite no grupo A foi de 0,22% (8:3.515 olhos) e no grupo B de 0,03% (1:3.680 olhos, p=0,0198, teste exato de Fischer). Não foi observada toxicidade ou inflamação relacionada com o uso de moxifloxacino intracameral. Conclusões: Houve uma proporção 7,3 vezes menor de endoftalmite no grupo que recebeu injeção de moxifloxacino. Este estudo fornece mais evidências que o moxifloxacino intracameral é um antibiótico profilático intracameral eficaz.

Prevalência de endoftalmite em um hospital universitário / Endophthalmitis prevalence in an university hospital

Objetivo Estudo da prevalência de endoftalmite em um hospital universitário, avaliando características epidemiológicas, tempo de sintomas, tratamento realizado e evolução clínica. Métodos Avaliação retrospectiva dos prontuários de pacientes com diagnóstico de endoftalmite, no período de janeiro de 2009 a junho de 2011, quanto às características epidemiológicas do paciente, causa da endoftalmite, tempo de início dos sintomas, tratamento prévio, tempo de internação, tratamento realizado, resultados de culturas, evolução clínica e acuidade visual final. Resultados Sessenta e oito pacientes, sendo 44 mulheres e 24 homens, com idade média de 56,99 anos, foram avaliados. A maioria foi referenciada de outro serviço (27,94%), já tinha sido submetida a algum tratamento clínico e/ou cirúrgico (45,59%) e possuía alguma comorbidade (60,29%) que decorreu de trauma (35,29%) ou pós-cirurgia (22,06%). O tempo médio de início dos sintomas foi de 5,76 dias e o de internação de 12,40 dias. A acuidade visual inicial e a final foram para ambas igual ou pior que percepção luminosa em 64,71% dos casos. A maior parte dos pacientes (58,82%) foi submetida apenas a tratamento clínico e, em 69,12% dos casos, a cultura foi negativa ou não foi realizada. Conclusão A endoftalmite é uma das complicações mais graves e de pior resultado funcional entre as afecções oftalmológicas. Seu diagnóstico rápido e correto é fundamental para um tratamento adequado e precoce, a fim de melhorar o prognóstico visual do paciente, garantindo sua qualidade de vida e posterior inserção socioeconômica...

Purpose To study endophthalmitis prevalence in an university hospital, assessing its epidemiological characteristics, symptoms onset, treatment and clinical outcome. Methods We retrospectively reviewed medical records of patients diagnosed with endophthalmitis, from january 2009 to june 2011, identifying patient epidemiological characteristics, endophthalmitis cause, onset of symptoms time, previous treatment, hospital stay, treatment, culture results, clinical outcome and final visual acuity. Results Sixty-eight patients, 44 women and 24 men, with a mean age of 56,99 years, were evaluated. Most were referred from other services (27,94%), had already undergone to any medical treatment and/or surgery (45,59%), presented some comorbidity (60,29%) and resulted from trauma (35,29%) or post-surgery (22,06%). The average duration of onset of symptoms was 5,76 days and of hospitalization was 12,40 days. Initial and final visual acuity were both equal to or worse than light perception in 64,71% of cases. Most of patients (58,82%) undergone to clinical treatment only and 69,12% of cases presented no results in culture. Conclusion Endophthalmitis is one of the most serious and worst functional outcome between ophthalmologic disorders. Its rapid and accurate diagnosis is essential for appropriate and early treatment, in order to improve patient visual prognosis, ensuring better quality of life and socioeconomic reintegration...

Microbiota conjuntival en el preoperatorio de pacientes que se someterán a cirugía de cataratas / Microbial flora isolated from patient's conjunctiva previous to cataract surgery

Background. Endophtalmitis post cataract surgery is one of most feared and devastating complications resulting in serious consequences and an uncertain visual prognosis. Antimicrobial prophylaxis against endophtalmitis must be based on the best knowledge of conjuntival microbiota. Objective: To establish microbiological basis for the best antibiotic prophylaxis to prevent endophthalmitis in cataract surgery. Materials and Methods: A descriptive, cross-sectional, prospective study. A preoperative conjunctival sample was taken from the lower fornix of 118 pacients, sowing it immediately in culture media. Identification of growing colonies and susceptibility testing were performed by manual or automated methods. Results: 106 (89.8%) of 118 preoperative cultures were positive. 159 bacteria were isolated in single or mixed flora, with 95% of Gram positive organisms. Staphylococci represented 76.1% of isolated bacteria, with 82.6% of coagulase-negative staphylococci (SCN) and 17.4% of Staphylococcus aureus. Forty two percent of SCN and 38% of S. aureus were methicillin resistan; both groups showed high susceptibility to tobramycin and fourth-generation fluoroquinolones. Conclusions: we recommend the use of topical tobramycin as pre-operative antimicrobial prophylaxis associated with povidone-iodine antisepsis. A fourth-generation quinolone is recommended when there is risk of infection.

Introducción: La endoftalmitis post-cirugía de cataratas es una de las complicaciones post-operatorias más temidas y devastadoras, pudiendo ocasionar secuelas graves, con un pronóstico visual incierto. La profilaxis antimicrobiana de esta complicación debe basarse en el conocimiento acabado de la microbiota presente en el territorio conjuntival. Objetivo: Establecer bases microbiológicas para una mejor profilaxis antimicrobiana de la endoftalmitis en cirugía de cataratas. Materiales y Métodos: Estudio descriptivo, de corte transversal, prospectivo. A 118 pacientes se les tomó muestra conjuntival pre-operatoria del fondo de saco inferior, sembrándola de inmediato en medios de cultivo. Las colonias desarrolladas se identificaron por métodos manuales y método de microdilución y difusión en disco. Resultados: De 118 cultivos pre-operatorios, 106 (89,8%) desarrollaron colonias bacterianas. Se aislaron 159 bacterias conjuntivales como especie única o cultivo mixta, siendo 95% grampositivas. El género Staphylococcus representó 76,1% del total de bacterias aisladas, siendo 82,6% Staphylococcus coagulasa negativa (SCN) y 17,4% Staphylococcus aureus. El 42% de los SCN y 38% de S. aureus presentaron resistencia a meticilina, presentando ambos buena susceptibilidad a tobramicina y fluoroquinolonas de cuarta generación. Conclusiones: Considerando nuestros resultados, recomendaríamos a nuestros pacientes tobramicina tópica como antibioprofilaxis, asociada a povidona yodada como antiséptico. Una quinolona de cuarta generación podría usarse cuando existan factores de riesgo de infección.

Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components

OBJECTIVE: To compare the efficacy and tolerability of a fixed combination of 0.3% gatifloxacin and 1% prednisolone (Zypred®) versus the individual components used separately (Zypred® and Predfort®) for infection prophylaxis and inflammation control after cataract surgery with intraocular lens implantation. METHODS: A prospective, randomized, double-blind, parallel-group study of 108 patients who underwent phacoemulsification and intraocular lens implantation was conducted. After random assignment, 47 eyes received the fixed combination of topical 0.3% gatifloxacin/1% prednisolone drops, and 61 eyes received the same doses of the individual components as separate solutions four times a day for 15 days. Baseline and postoperative assessments were made on postoperative days 1, 7, 15, and 20. RESULTS: All objective (best corrected visual acuity, sign of active ocular inflammation, central and incisional corneal edema, the number of cells per high-power field in the anterior chamber, and intraocular pressure) and subjective (eye pain, photophobia, burning sensation, itching, and foreign body sensation) criteria of efficacy were similar in both groups, with no significant differences. Group I included 47 eyes that received the fixed combination of gatifloxacin/prednisolone acetate eye drops and a placebo eye drop solution. Group II included 61 eyes that were treated with 0.3% gatifloxacin and 1% prednisolone acetate eye drops separately. The intraocular pressure was slightly higher in Group II (p<0.05). CONCLUSION: Treatment with the fixed-dose combination of gatifloxacin/prednisolone eye drops was as effective as the non-fixed combination in preventing infection and controlling inflammation after phacoemulsification and intraocular lens implantation. .

Efficacy and Safety of Intracameral Moxoft Eye Drops (Moxifloxacin Ophthalmic Solution 0.5%) for Endophthalmitis Prophylaxis in Cataract Surgery.

Objective: To evaluate the efficacy and safety of intracameral Moxoft eye drops (Moxifloxacin ophthalmic solution 0.5%) administered at the conclusion of phacoemulsification cataract surgery for the purpose of endophthalmitis prophylaxis. Design: Open label, multicentre, prospective. Setting: Three ophthalmologists across India. Methods: A total of 134 outpatients of either sex undergoing phacoemulsification with no ocular pathology other than cataract and meeting all inclusion/exclusion criteria were enrolled in the study. All patients received preoperatively 1 drop of Moxoft eye drops (Moxifloxacin ophthalmic solution 0.5%) topically every 15 minutes atleast 4 times one hour prior to surgery. 0.1 ml moxifloxacin solution was aspirated into the tuberculin syringe and injected into the capsular bag under the capsulorhexis edge after completion of the Phacoemulsification and IOL implantation. Post-operative treatment was as per standard protocol. Patients were assessed pre-operatively and on day 1, day 7 & day 30 after surgery for ocular symptom scores for pain in eyes, ocular discharge, hazy cornea, conjunctival hyperemia, and hypopyon and chemosis. Anterior chamber (AC) reaction was graded (if present) on all the visits with fixed slit-lamp settings and on 5-point rating scale for AC flare and cells in AC. Global assessment was done for efficacy and tolerability at the end of therapy on a 3-point scale. Result: Thirteen patients were excluded from the analysis due to insufficient data and an intentionto- treat analysis was done for efficacy on 121 patients. There was significant reduction in scores of pain in eyes, conjunctival hyperemia, mean AC flare, mean AC cells (p<0.0001 for all) and ocular discharge (p=0.018). Hypopyon and/or corneal endothelial cell damage was observed in none of the patients. Therapy was rated good to excellent on efficacy and tolerability parameters with no reporting of a poor rating. Conclusion: Moxoft eye drops (Moxifloxacin ophthalmic solution 0.5%) is safe for use by intracameral administration with no corneal decompensation. Tolerability and post-operative results were found to be excellent.

Efficacy of Intracameral moxifloxacin in Cataract surgery to prevent post-operative Endophthalmitis

To establish the efficacy of intracameral injection of moxifloxacin 0.5% [0.5 mg/ml or 500 micro g] ophthalmic solution in patients having routine cataract surgery as prophylaxis to endophthalmitis. Department of Ophthalmology, Sindh Government Qatar Hospital Orangi Town, Karachi. Prospective Case Series. A prospective study was conducted from the period of February 2009 to November 2009 in department of ophthalmology Sindh Government Qatar Hospital Orangi Town, Karachi. Total 530 patients were treated with intracameral injection of 0.5% moxifloxacin solution in 0.1 [500 micro g] ml dose at the conclusion of the surgery with IOL implantation either by doing phacoemulsification or conventional method. Safety parameters included VA, IOP, corneal clarity and edema, aqueous cells and flare were evaluated preoperatively and postoperatively for 3 months in patients who received intracameral injection. Five hundred eyes completed the study while 30 patients were excluded from the study because of poor follow up. Aqueous cells and count on first and third postoperative days were insignificant in all patients who were given intracameral injection of moxifloxacin at the last step of surgery. All eyes had a postoperative best corrected visual acuity of 20/30 or better. No stromal edema was observed. No drug related adverse effects were reported. No case of endophthalmitis was reported during and after the 3 months follows up period. Intracameral injection of moxifloxacin 0.5% [0.5mg/ml or 500 micro g] ophthalmic solution appears to be nontoxic in terms of visual rehabilitation, anterior chamber reaction and corneal edema. It is found very effective for the prophylaxis of endophthalmitis at the conclusion of routine cataract surgery

Técnica para injeção intravítrea de drogas no tratamento de doenças vítreorretinianas / Technique of intravitreal drug injection for therapy of vitreoretinal diseases

A injeção intravítrea é atualmente a técnica mais utilizada no tratamento de várias doenças vítreorretinianas. Neste artigo serão discutidas a técnica e complicações da injeção intravítrea de drogas no tratamento de doenças vítreorretinianas. Em resumo, a técnica envolve várias etapas. Inicialmente dias antes da injeção pode-se realizar aplicação de antibióticos e acetazolamida para prevenção de infecção e redução da pressão intra-ocular. Antes do procedimento deve-se dilatar a pupila e executar anestesia tópica com colírios ou gel anestésico. A antissepsia pré-operatória envolve aplicação de colírios de iodo-povidona 5 por cento no fundo de saco conjuntival ao menos 10 minutos antes do procedimento. A injeção deve ser realizada no centro cirúrgico com uso de luvas estéreis e máscara pelo cirurgião. O olho deve ser exposto com blefarostato estéril, e proteção com "sterile-drape" para evitar contato entre a agulha e pálpebras/cílios. A agulha deve ser posicionada no momento da injeção a 3,5 - 4 mm do limbo, e leve mobilização da conjuntiva com um cotonete estéril ou uma pinça facilitam a penetração da agulha através da conjuntiva e esclera. A agulha deve ser inserida gentilmente para dentro da cavidade vítrea até 6 mm de profundidade. Imediatamente após a injeção o paciente deve ser examinado por técnica de oftalmoscopia binocular indireta. Caso a acuidade visual seja ausência de percepção luminosa ou oclusão vascular arterial retiniana seja observada, terapias para diminuição da pressão como paracentese na camada anterior ou massagem por oculopressão diretamente sobre o globo ocular devem ser imediatamente tomadas. A alta ambulatorial deve ser realizada quando o cirurgião estiver ciente da ausência de complicações intra-operatórias; o paciente deverá sair do centro cirúrgico com curativo oclusivo. O paciente deve ser submetido a exame oftalmológico completo no primeiro dia pós-operatório quando associação de antibióticos com corticosteróides...

Intravitreal injections are the standard technique applied in the treatment of some vitreoretinal diseases. In this paper the technique and complications of intravitreal injections are presented. In summary, the procedure involves various consecutive steps. Initially, days before the treatment topical antibiotics and acetazolamide may be prescribed for reduction of the ocular flora and intraocular pressure. Before the injection, the pupil should be dilated and topical anesthesia should be achieved. Injection shall be performed in the operating room under sterile conditions, the surgeon should wear surgical gloves and mask. The eye is then exposed with sterile blepharostat and sterile-drape thereby providing protection of the needle against the contact with contaminated lashes and lids. Injection is done 3.5 mm from the limbus through the pars plana. The needle should be inserted up to 6 mm into the vitreous cavity. Immediately after injection the patient must be examined by indirect ophthalmoscopy to verify central artery perfusion and complications as vitreous hemorrhage. Visual acuity better than light perception should be detected right after injection. If persistent central retinal artery occlusion is diagnosed, anterior chamber paracentesis should be performed. The patient may be discharged with an occlusive patch. Examination at the first postoperative day should exclude various complications such as endophthalmitis, and topical steroid and antibiotics should be prescribed for 7 days. Some complications encountered after intravitreal injections include retinal detachment, vitreous hemorrhage, cataract, uveitis, ocular hypertension, or endophthalmitis.

Flora bacteriana conjuntival após uso tópico de ciprofloxacino e gatifloxacino em cirurgia de catarata / Conjunctival bacterial flora after topical use of ciprofloxacin and gatifloxacin in cataract surgery

OBJETIVO: Avaliar alterações da flora conjuntival após uso dos colírios de ciprofloxacino e gatifloxacino 0,3 por cento na profilaxia dos pacientes submetidos à facectomia. MÉTODOS: Quarenta pacientes submetidos a facectomia foram alocados em dois grupos, conforme o colírio antibiótico utilizado: Grupo A: ciprofloxacino 0,3 por cento e Grupo B: gatifloxacino 0,3 por cento. Os pacientes usaram os colírios 1 hora antes da cirurgia e nos primeiros 14 dias pós-operatórios. Foi coletado material da conjuntiva em cinco momentos: 1 hora antes da cirurgia, sem medicações tópicas (t0); imediatamente antes da aplicação de iodopovidona (PVPI) (t1), antes do início da cirurgia, após iodopovidona (t2), 14 dias após a cirurgia (t3) e 28 dias após a cirurgia (t4). RESULTADOS: O uso de antibióticos no pré-operatório diminuiu a positividade das culturas anteriores ao uso do iodopovidona em ambos os grupos; no Grupo A esta redução não alcançou significância estatística (Grupo A - p=0,07 e Grupo B - p=0,04). A positividade das culturas foi reduzida nos dois grupos após aplicação de iodopovidona e 14 dias após a cirurgia (p<0,05). Em t4 a freqüência do Staphylococcus coagulase-negativo foi menor no grupo A quando comparado ao grupo B (p<0,05) e a sensibilidade ao ciprofloxacino em relação a t0 foi menor em todos grupos. CONCLUSÃO: O colírio de gatifloxacino aplicado 1 hora antes da cirurgia reduziu significantemente a positividade das culturas. Ambos antibióticos promoveram redução da flora quando administrados no pós-operatório.

PURPOSE: To evaluate alterations of the conjunctival flora after the use of 0.3 percent ciprofloxacin and gatifloxacin in the prophylaxis of patients undergoing cataract surgery. METHODS: 40 patients undergoing cataract surgery were distributed into two groups according to the use of antibiotic eye drops: Group A: 0.3 percent ciprofloxacin and Group B: 0.3 percent gatifloxacin. Both groups used antibiotic eye drops 1 hour before surgery and 14 days after surgery. Conjunctival material was collected at 5 time points: 1 hour before surgery, without any topical medication (t0); immediately before the application of povidone-iodine (PVPI) (t1), before the beginning of surgery, after povidone-iodine (t2), 14 days (t3) and 28 days after surgery (t4). RESULTS: Preoperative antibiotics reduced the positivity of the cultures before the use of PVPI in both groups, although in Group A this reduction was not significant (Group A - p=0.07 and Group B - p=0.04). The number of positive cultures was reduced in all groups after the use of povidone-iodine and on the 14th postoperative day (p<0.05). In t4 there was a reduction in the frequency of coagulase-negative Staphylococcus in Group A compared with Group B (p<0.05); the susceptibility to ciprofloxacin was also reduced in all groups, when compared with t0. CONCLUSIONS: Gatifloxacin eye drops applied one hour before surgery significantly reduced the number of positive conjunctival cultures. Both antibiotics reduced the conjunctival flora when administered in the postoperative period.

Evaluación prospectiva de la combinación colirio-ungüento de ciprofloxacino-dexametasona y tobramicina-dexametasona en cirugía de catarata / Prospective evaluation of eye drops and ointments of ciprofloxacin/dexamethasone versus tobramycin/dexamethasone combinations in ocular surgery

El uso profiláctico de antibióticos y antiinflamatorios post cirugía oftálmica es una práctica común. La tobramicina es aminoglicósido con espectro de gram negativos y alguns gram positivos. Ciprofloxacino tiene un mayor espectro. Objetivo: Comparar la eficacia y seguridad de la combinación colirio y ungüento de cirpofloxacino/dexametasona versus tobramicina/dexametasona. Pacientes y métodos: Se estudio en forma randomizada y doble ciego, 64 pacientes durante 15 días. Se realizaron 3 controles donde se registró agudeza visual, presión intraocular y una escala subjetiva y objetiva. Resultados: 60 pacientes completaron el estudio. El prurito fue menor en el grupo tratado con ciprofloxacino (0.26 v/s 0.47; p<0,05). Conclusiones: El estudio demostró eficacia y seguridad antibiótica equivalente entre ambas combinaciones. Considerando el mayor espectro antibacteriano de ciprofloxacino y la menor incidencia de prurito se plantea que el uso de esta combinación en pacientes post cirugía de catarata entregaría una protección antibiótica segura y con espectro más amplio.

The prohylactic use of antibiotics and anti-inflammatories drugs is a common practice in ophthalmic surgery. Tobramycin is an aminoglycoside with gram negative spectrum, covering some gram positive bacteria. Ciprofloxacin has a broader spectrum of effectivity. Purpose: To compare effectiveness and safety of eye drops and ointments of ciprofloxacim/dexamethasone versus tobramysin/dexamethasone combinations. Patients and methods: Random and doubled masked study, performed in 64 patients who had cataract surgery. In a 15 days follow up, the effectiveness of both antibiotic combinations were tested. Visual acuity, intraocular pressure, objective and subjective scale were performed. Results: 60 patients (93.4 percent) completed the follow up. Itching presented a significant difference between both groups, being lower in the ciprofloxacin/dexamethasone combination (0.26 vs 0.47. p<0.05). Conclusions: The study shows an equivalent effectiveness and safety of both antibiotic combinations. Considering the broader spectrum of ciprofloxacin and the lower frequency of itchness, ciprofloxacin/dexamethasone combination seems to be a good choice for post operative treatment in cataract surgery.

A Case of Inadvertent Anterior Chamber and Corneal Stromal Injection with Antibiotics during Cataract Operation

PURPOSE: To report a case of inadvertent anterior chamber and cornea stromal injection with high dose antibiotics and steroids during cataract operation. METHODS: During cataract operation on a 78 year-old female patient, high dose gentamicin (20 mg/0.5 ml) and dexamethasone (2 mg/0.5 ml) were inadvertently injected into the anterior chamber and cornea stroma when making cornea edema for sealing of the incision sites. Anterior chamber irrigation with balanced salt solution (BSS) was immediately administered. On postoperative day one, extensive cornea edema was noted, and best-corrected visual acuity was 0.2. Descemet's membrane folds were observed around the corneal incision sites. Topical 5% NaCl and 1% prednisolone were started. RESULTS: Four weeks postoperatively, corneal edema began to reduce significantly. At four months postoperatively, corneal edema fully resolved, and best-corrected visual acuity was 0.8. However, some Descemet's membrane folds still remained, and a decrease in the number of endothelial cells was noted by specular microscope. CONCLUSIONS: In this case involving anterior chamber and cornea stromal injection with high dose antibiotics and steroids, immediate anterior chamber irrigation with balanced salt solution seemed an appropriate management, and the patient's long-term visual acuity appears good. To prevent such mistakes, precise labeling of all solutions and use of different syringe needles should be considered.

Role of prophylactic intravitreal antibiotics in open globe injuries.

PURPOSE: To determine the efficacy of prophylactic intravitreal antibiotics in reducing the incidence of endophthalmitis after trauma. METHODS: This was a prospective, randomised, case control study of 70 consecutive patients with open globe injury. The patients were prospectively randomised into group I (32 eyes) and group II (38 eyes). Group I patients were given prophylactic intravitreal injection of vancomycin 1 mg and ceftazidime 2.25 mg at the conclusion of primary repair. Group II patients were not given prophylactic intravitreal antibiotics. All the patients received intravenous ciprofloxacin. RESULTS: The incidence of endophthalmitis was higher in group II (7 of 38 eyes; 18.42%) compared to group I (2 of 32 eyes; 6.25%). Both the patients who developed endophthalmitis despite prophylactic intravitreal antibiotics in group I had an initially undetected intraocular foreign body (eyelash) in the vitreous cavity. CONCLUSIONS: Prophylactic intravitreal broad spectrum antibiotic injection decreases the risk of post-traumatic endophthalmitis.

Profilaxis de la endoftalmitis infecciosa postquirúrgica / Profilaxis of infectious postsurgical endophthalmitis

La Endoftalmitis Infecciosa postquirúrgica en la complicación más molesta y seria después de una cirugía exitosa. Su profilaxis incluye variadas medidas, siendo las más importantes eliminar en el preoperatorio los focos infecciosos, cultivos palpebrales y conjuntivales en casos seleccionados, retirar prótesis y lentes de contacto, renovar fármacos tópicos crónicos por su eventual contaminación, antibióticos profilácticos en el pre y peroperatorio, suspender la operación si el paciente se presenta en el quirófano con ojo rojo, meibomitis aguda, resfrío, fiebre o cualquier enfermedad intercurrente aguda. Otras medidas no menos importantes son cumplir estrictamente las normas de asepsia y antisepsia en pabellón quirúrgico, uso de solución de povidona iodada al 5 por ciento en fondos de saco conjuntivales, realizar un adecuado campo quirúrgico y practicar una técnica quirúrgica depurada

Hialuronato de sódio como veículo para gentamicina intraocular: estudo "in vivo" - Parte I / Sodium hyaluronate as a Carrier for intraocular gentamicin: \"in vivo\" study - part I

A procura de métodos capazes de prevenir a endoftalmite bacteriana, os autores avaliaram a associaçäo de gentamicina com hialuronato de sódio (HS) a 0,8//, em volumes de 0,1 ml, injetados na câmara anterior de olhos de coelho. Foram realizadas facectomias extra-capsulares com capsulotomias posteriores, e inoculaçäo de 10.000 UFC de P. aeruginosa no vítreo anterior. Os olhos foram divididos em grupos (grupo I=näo recebeu tratamento, II=50 mcg de gentamicina aquosa, III- hialuronato de sódio a 0,8//, IV = 50 mcg de gentamicina com HS a 0,8//) recebendo o tratamento na câmara anterior logo após o procedimento cirúrgico, segundo distribuiçäo prévia. O grupo I apresentou endofalmite em 100// dos olhos, o grupo II em 67//., o grupo III em 93// e o grupo IV apresentou endoftalmite em apenas 27// dos olhos operados. Os testes de farmacocinética para gentamicina demonstraram que a meia vida do antibiótico ao HS aumentava a meia vida para 132 minutos. Näo foi demonstrado aumento da PIO ou evidência de toxicidade retiniana com este novo método de tratamento

Incidência e profilaxia de endoftalmites em facectomias eletivas / Incidence and prophylaxis of the endophthamitis in elective cataract extraction

Analisaram-se retrospectivamente 2697 facectomias eletivas feitas em 1966 pacientes, operados entre janeiro de 1979 e junho de 1986 na Clínica Oftalmológica do Hospital das Clínicas da Faculdade de Medicina da Universidade de Säo Paulo. Avaliou-se a incidência de endoftalmites pós-operatórias, a profilaxia antibiótica utilizada e o papel dos fatores predisponentes. Verificaram-se cinco casos de endoftalmite infecciosa pósóperatória (0,18%). Quatro ocorreram após extraçäo intracapsular (0,22%) e um após extraçäo extracapsular (0,13%) da catarata. Todos receberam alguma forma de antibiótico profilático. Diabetes, cirurgia intraocular ou perda vítrea näo foi observado em nenhum destes casos. A técnica extracapsular näo pareceu ser fator predisponente no aparecimento das endoftalmites